What Eli Lilly ( LLY -0.05%) is doing is far more impressive. The company has been increasing its dividend at a high rate, ...

Goldman Sachs’ Asad Haider likes the prospects for medical technology companies, mid-cap biotechs, drug distributors.

(This Dec. 17 story has been corrected to say that the EU regulator reversed its July decision in November to recommend ...

The Richmond company (Nasdaq: BIOA) will get a fraction of the money upfront from Novartis (NYSE: NVS) — up to $20 million, ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

TAKEAWAYS FROM THE HEALTH CARE DEAL — Pharmacy benefit managers may soon have to comply with new regulations under an ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and ...

The Village of Pleasant Prairie Plan Commission on Monday approved the preliminary site and operational plans for the ...

But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...

Eli Lilly’s recently announced plan to partner with digital health company Ro on its LillyDirect platform marks a new turning ...

Merck announces a $2.0 billion agreement with Hansoh Pharma. The deal gives it rights to Hansoh's experimental weight-loss ...